Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 536-544

  Novak Hofer, Use ^b   Zimmermann, Kurt ^b   Maecke, Helmuth R ^b   Amstutz, Hans Peter ^b   Carrel, François ^b   August Schubiger, P ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b NONE

Author keywords

antineuroblastoma antibody chCE7; copper 67; radiolabeled antibody metabolism; radiolabeled antibody therapy

Indexed keywords

ANTIBODY CONJUGATE; COPPER 67; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY LABELING; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DEGRADATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; KIDNEY PARENCHYMA; MOUSE; NEUROBLASTOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; AZA COMPOUNDS; BENZOATES; BENZOIC ACIDS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER RADIOISOTOPES; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; TISSUE DISTRIBUTION;

EID: 0030948146     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cheung NK, Yeh SDJ, Gulati S, et al. Iodine-131-3F8 targeted radiotherapy of neuroblastoma: a phase I clinical trial. Proc Am Assoc Cancer Res 1990:31:284.
2. Doerr U. llaldemann AR, Lcihundgut K. et al. First clinical results with the chimeric antibody chCE7 in neuroblastoma: targeting features and biodistribution data [Abstract], F.ur.I Nucl Med 1993:20:858.
3. Yeh SDJ, Larson SM. Burch L, et al. Radioimmunodetection of neuroblastoma with iodine-13I-3F8: correlation with biopsy, iodine-131-meta iodobenzylguanidine and standard diagnostic modalities. J Nucl Med 1990:32:769-776.
4. Novak-Hoter I. Amstutz H. Morgenthaler JJ. et al. Intcrnalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells. Im J Cancer 1994:57: 427-432.
5. Novak-Hofer I. Amstutz H, llaldemann A. et al. Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. J Nucl Med 1992:33:231-236.
6. Novak-Hofcr I, Amstutz H, Macke HR. et al. Cellular processing of copper-67-labelcd monoclonal antibody chCE7 by human neuroblastoma cells. Cancer Res 1995:55:46-50.
7. Antstutz H. Rytz CH. Novak-Hofer I. et al. Production and characterization of mouse/human chimeric antibody directed against human neuroblastoma. Int J Cancer 1993:53:137-152.
8. X. Bucheggcr F, Pelegrin A. Delaloye B. et al. Iodine-131-labeled MAb F(ab'), fragments are more efficient and less toxic than intact anti-CEA antibodies in radioiinmunotherapy of large human colon carcinoma grafted in nude mice. J Nucl Med 1990:31:1035-1044.
9. 67Cu-labelcd intact and fragmented anti-colon carcinoma monoclonal antibody MAb35. Cancer Res 1993:53:5727-5733.
10. Anderson CJ. C'onnett JM. Schwarz SW, et al. Copper-64-labeled antibodies for PF.T imaging. f^ticl Med 1992:33:1685-1691.
11. Mausncr LF. Srivastaa SC. Kolsky KE. et al. Development and evaluation of copper-67 labeled DOTA and TETA immunoconjugates for radioimmunotherapy lAbstract]. J Labelled Compounds Radiopharm 1994:35:374-376.
12. 2+ complex towards amide formation and its use as a protein-labeling agent. Helv Chim Acta 1990:73:149 -153.
13. Ruser G. Ritter W. Maecke HR. Synthesis and evaluation of two new bifunctional carhoxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111. Riuconj i'hem 1990:2:345-349.
14. 67Cu from irradiated zinc for use in antibody labelling: a comparison (if methods. Appl Radial Isol 1995:46:329-336.
15. Mearcs C'F. McCall M.I, Reardan DT. et al. Conjugation of antibodies with bifunclional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis and subsequent addition of mental ions. Anal Biochem 1984;142:68-78.
16. Smith-Jones PM. Fridrich R. Kaden TA. et al. Antibody labeling with copper-67 using the bifnnctional macrocycle 4-[l,4.8.1 l-tetraazacyclotetradec-1-yl-methyl] benzoic acid. Kioeimj Chem 1991:2:415-421.
17. Deshpandc SV. DcNardo SJ, Meares CF. et al. Copper-67 labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribulion in RA.II tumorcd mice. J Nucl Med 1988:29:217-225.
18. IK. De Nardo GL, De Nardo SJ, Meares C'F. et al. Pharmacokinetics of copper-67 conjugates Eym-1, a potential therapeutic radioimmunoconjugate in mice and in patients with lymphoma. Anfih Ini/niinocon/ Radio/ihann 1991:4:777-785.
19. Franano FN. Edwards WB, Welch MJ. et al. Metabolism of receptor targeted '"in-DTPA-glycoproteins: identification of ' "In-DTPA-e-lysine as the primary metabolic and excretory product, Nucl Med Biol 1994:5:1023-1034.
20. Pinun MV. Circulating antigen: bad or good for immunoscintigraphy? Nucl Med Biol 1995:22:137 -145.
21. Larson SM. Pentlou KS. Volkow ND, et al. PET scanning of iodine-124-3F9 as an apptoach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med 1992:33:2020-2023.
22. Siddiqui A. Ouadri SM. Griffith GE. et al. Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (immuno-14). Nucl Med Biol 1995:4:425-435.
23. Studer M. Kroger I.A. De Nardo S.I, et al. Influence of a peptide linker on biodistribution and metabolism of antibody-conjugates benzyl-F.DTA: comparison of enzymatic digestion in xitro and in vivo. Biuconj Chem 1992:3:424-429.
24. Li M, Meares CF. Synthesis, metal chelate stability studies and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconj Ligates. Bioconj Chem 1993;4:275-283.
25. De Nardo SJ, Zhong G-R, Salako Q, et al. Pharmacokinetics of chimcric L6 conjugated to indium-Ill and yttrium-90-DOTA-peptide in tumor-bearing mice. J Nucl Med 1995;36:829-836.
26. Anderson CJ, Rogers BE, Connett JM. Comparison of two bifunctional chelate; for labeling MCu to MAb 1A3 and 1A3 F(ab')2: chemistry and animal biodistribution [Abstract]. J Labelled Compounds Radiopharm 1994:35:313-315.
27. Anderson CJ, Schwarz SW, Connett JM, et al. Preparation, biodistribution and dosimetry of Copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1 A3 F(ab')2. J Nucl Meet 1995:36:850-858.